In comparison to a healthy control group with a median of 29.96%, the percentage of CD163 positive cells is significantly lower in Lyme borreliosis patients (median: 5%) (Figure 1; Mann-Whitney-U test p < 0.0001). The gene discussed is CD163; the disease is Lyme disease.